- Home
- PRPH vs CODX Comparison
PRPH vs CODX Comparison
Compare PRPH & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPH
- CODX
- Stock Information
- Founded
- PRPH 1989
- CODX 2013
- Country
- PRPH United States
- CODX United States
- Employees
- PRPH N/A
- CODX N/A
- Industry
- PRPH Biotechnology: Pharmaceutical Preparations
- CODX Medical/Dental Instruments
- Sector
- PRPH Health Care
- CODX Health Care
- Exchange
- PRPH Nasdaq
- CODX Nasdaq
- Market Cap
- PRPH 10.7M
- CODX 11.9M
- IPO Year
- PRPH 1997
- CODX 2017
- Fundamental
- Price
- PRPH $0.37
- CODX $0.31
- Analyst Decision
- PRPH
- CODX Buy
- Analyst Count
- PRPH 0
- CODX 2
- Target Price
- PRPH N/A
- CODX $5.50
- AVG Volume (30 Days)
- PRPH 748.2K
- CODX 254.5K
- Earning Date
- PRPH 05-20-2025
- CODX 05-08-2025
- Dividend Yield
- PRPH N/A
- CODX N/A
- EPS Growth
- PRPH N/A
- CODX N/A
- EPS
- PRPH N/A
- CODX N/A
- Revenue
- PRPH $6,770,000.00
- CODX $3,497,583.00
- Revenue This Year
- PRPH $221.82
- CODX N/A
- Revenue Next Year
- PRPH N/A
- CODX N/A
- P/E Ratio
- PRPH N/A
- CODX N/A
- Revenue Growth
- PRPH N/A
- CODX N/A
- 52 Week Low
- PRPH $0.22
- CODX $0.28
- 52 Week High
- PRPH $5.62
- CODX $2.23
- Technical
- Relative Strength Index (RSI)
- PRPH 53.73
- CODX 35.82
- Support Level
- PRPH $0.30
- CODX $0.32
- Resistance Level
- PRPH $0.38
- CODX $0.50
- Average True Range (ATR)
- PRPH 0.04
- CODX 0.05
- MACD
- PRPH 0.01
- CODX 0.00
- Stochastic Oscillator
- PRPH 75.27
- CODX 16.25
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.